Insider Buying: Mallinckrodt PLC (MNK) CEO Buys 2,000 Shares of Stock
Mallinckrodt PLC (NYSE:MNK) CEO Mark Trudeau acquired 2,000 shares of the firm’s stock in a transaction dated Thursday, May 30th. The shares were acquired at an average price of $9.26 per share, for a total transaction of $18,520.00. Following the acquisition, the chief executive officer now directly owns 233,254 shares of the company’s stock, valued at $2,159,932.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Mark Trudeau also recently made the following trade(s):
- On Thursday, May 9th, Mark Trudeau acquired 1,000 shares of Mallinckrodt stock. The shares were acquired at an average price of $16.33 per share, for a total transaction of $16,330.00.
- On Tuesday, March 5th, Mark Trudeau acquired 1,000 shares of Mallinckrodt stock. The shares were acquired at an average price of $22.65 per share, for a total transaction of $22,650.00.
NYSE:MNK opened at $8.69 on Friday. The company has a debt-to-equity ratio of 1.90, a quick ratio of 1.08 and a current ratio of 1.45. Mallinckrodt PLC has a 12 month low of $8.42 and a 12 month high of $36.65. The stock has a market capitalization of $758.52 million, a price-to-earnings ratio of 1.08, a P/E/G ratio of 0.09 and a beta of 2.12.
A number of large investors have recently added to or reduced their stakes in the business. QS Investors LLC raised its position in Mallinckrodt by 14.3% in the fourth quarter. QS Investors LLC now owns 4,000 shares of the company’s stock valued at $64,000 after purchasing an additional 500 shares during the period. Sheaff Brock Investment Advisors LLC increased its position in shares of Mallinckrodt by 4.6% during the fourth quarter. Sheaff Brock Investment Advisors LLC now owns 13,440 shares of the company’s stock worth $212,000 after acquiring an additional 594 shares during the last quarter. Martingale Asset Management L P increased its position in shares of Mallinckrodt by 0.8% during the fourth quarter. Martingale Asset Management L P now owns 76,053 shares of the company’s stock worth $1,202,000 after acquiring an additional 597 shares during the last quarter. Retirement Systems of Alabama increased its position in shares of Mallinckrodt by 0.6% during the first quarter. Retirement Systems of Alabama now owns 108,703 shares of the company’s stock worth $2,363,000 after acquiring an additional 685 shares during the last quarter. Finally, Arizona State Retirement System increased its position in shares of Mallinckrodt by 1.2% during the fourth quarter. Arizona State Retirement System now owns 59,797 shares of the company’s stock worth $945,000 after acquiring an additional 714 shares during the last quarter.
Several equities research analysts have recently issued reports on MNK shares. Canaccord Genuity set a $40.00 price objective on Mallinckrodt and gave the stock a “buy” rating in a report on Monday, March 18th. Mizuho decreased their price objective on Mallinckrodt from $25.00 to $22.00 and set a “neutral” rating on the stock in a report on Thursday, May 16th. Morgan Stanley set a $32.00 target price on Mallinckrodt and gave the company a “hold” rating in a report on Thursday, February 28th. Berenberg Bank reiterated a “sell” rating and issued a $5.00 target price (down previously from $10.00) on shares of Mallinckrodt in a report on Tuesday, May 21st. Finally, ValuEngine upgraded Mallinckrodt from a “sell” rating to a “hold” rating in a report on Monday, February 4th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $24.56.
Mallinckrodt Company Profile
Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza.
Further Reading: What are Institutional Investors?
Receive News & Ratings for Mallinckrodt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt and related companies with MarketBeat.com's FREE daily email newsletter.